Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Total Current Liabilities (2016 - 2025)

Palisade Bio has reported Total Current Liabilities over the past 16 years, most recently at $4.6 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 43.26% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, up 43.26% year-over-year, with the annual reading at $4.6 million for FY2025, 43.26% up from the prior year.
  • Total Current Liabilities was $4.6 million for Q4 2025 at Palisade Bio, up from $3.5 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $4.6 million in Q4 2025 and troughed at $1.0 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $2.8 million (2024), against an average of $2.8 million.
  • The largest YoY upside for Total Current Liabilities was 469.55% in 2021 against a maximum downside of 69.12% in 2021.
  • A 5-year view of Total Current Liabilities shows it stood at $2.5 million in 2021, then grew by 20.67% to $3.0 million in 2022, then fell by 14.14% to $2.6 million in 2023, then grew by 25.14% to $3.2 million in 2024, then skyrocketed by 43.26% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Total Current Liabilities are $4.6 million (Q4 2025), $3.5 million (Q3 2025), and $4.0 million (Q2 2025).